Martini Gregory S.
- SEC CIK
- 0002053936
In the past year, 1 open-market sale filing worth $81.9K and no purchases.
Current role at each company
- KYTX Kyverna Therapeutics, Inc.Chief Financial Officeras of May 20, 2026
- IRWD Ironwood Pharmaceuticals IncChief Financial Officeras of Mar 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $81.9K
- 1 filing
- Net
- −$81.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Martini Gregory S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IRWD Ironwood Pharmaceuticals Inc
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 (view filing) | Feb 23-24 | 2 days | Martini Gregory S.Chief Financial Officer | SSaleClass A Common Stock | −21.9K | $3.73 | −$81.9K | −12.0%160.6K after | 2 lots |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Martini Gregory S.Chief Financial Officer | SSaleClass A Common Stock | −1.26K | $0.84 | −$1.06K | −0.7%182.5K after | |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Martini Gregory S.Chief Financial Officer | SSaleClass A Common Stock | −12.1K | $1.76 | −$21.2K | −6.2%183.8K after |